US3857961A - Method for producing foie gras by induction of hyperphagia in geese - Google Patents
Method for producing foie gras by induction of hyperphagia in geese Download PDFInfo
- Publication number
- US3857961A US3857961A US00273671A US27367172A US3857961A US 3857961 A US3857961 A US 3857961A US 00273671 A US00273671 A US 00273671A US 27367172 A US27367172 A US 27367172A US 3857961 A US3857961 A US 3857961A
- Authority
- US
- United States
- Prior art keywords
- injection
- hyperphagia
- dopamine
- geese
- goose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 206010020710 Hyperphagia Diseases 0.000 title claims abstract description 21
- 230000006698 induction Effects 0.000 title claims abstract description 10
- 241000272517 Anseriformes Species 0.000 title abstract description 21
- 238000004519 manufacturing process Methods 0.000 title abstract description 7
- 241001465754 Metazoa Species 0.000 claims abstract description 35
- 239000000126 substance Substances 0.000 claims abstract description 20
- 210000001175 cerebrospinal fluid Anatomy 0.000 claims abstract description 9
- 239000007924 injection Substances 0.000 claims description 27
- 238000002347 injection Methods 0.000 claims description 27
- 238000000034 method Methods 0.000 claims description 24
- 229960003638 dopamine Drugs 0.000 claims description 19
- 241000272814 Anser sp. Species 0.000 claims description 16
- 230000002267 hypothalamic effect Effects 0.000 claims description 13
- 210000004185 liver Anatomy 0.000 claims description 8
- 210000000211 third ventricle Anatomy 0.000 claims description 3
- 230000002440 hepatic effect Effects 0.000 abstract description 3
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 5
- 241000287828 Gallus gallus Species 0.000 description 3
- 206010019708 Hepatic steatosis Diseases 0.000 description 3
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 3
- 235000013330 chicken meat Nutrition 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 210000003016 hypothalamus Anatomy 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 229960004502 levodopa Drugs 0.000 description 3
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 2
- 208000035943 Aphagia Diseases 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 150000003943 catecholamines Chemical class 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- 230000001969 hypertrophic effect Effects 0.000 description 2
- 238000007914 intraventricular administration Methods 0.000 description 2
- 229960002748 norepinephrine Drugs 0.000 description 2
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 2
- DIVDFFZHCJEHGG-UHFFFAOYSA-N oxidopamine Chemical compound NCCC1=CC(O)=C(O)C=C1O DIVDFFZHCJEHGG-UHFFFAOYSA-N 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- 235000013594 poultry meat Nutrition 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 235000019733 Fish meal Nutrition 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 239000000150 Sympathomimetic Substances 0.000 description 1
- IUJDSEJGGMCXSG-UHFFFAOYSA-N Thiopental Chemical compound CCCC(C)C1(CC)C(=O)NC(=S)NC1=O IUJDSEJGGMCXSG-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229940046545 animal allergen extract Drugs 0.000 description 1
- 210000003323 beak Anatomy 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000021474 generally recognized As safe (food) Nutrition 0.000 description 1
- 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229940043200 pentothal Drugs 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000009666 routine test Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000033912 thigmotaxis Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
- A61D7/00—Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals
Definitions
- ABSTRACT Primary Examiner-Hyman Lord Attorney, Agent, or Firm--Burgess, Dinklage & Sprung 5 7 ABSTRACT A method for producing foie gras by induction of hyperphagia in animals, particularly in geese.
- It comprises the administration of an effective amount of an anti-catecholamine substance in the cerebrospinal fluid of the animal.
- anti-catecholamine substances notably permits the induction of an hepatic hypersteatosis in animals.
- a particularly advantageous field of application of the invention is that of the manufacture of so-called foie gras, that is to say, the livers of crammed animals, and notably geese.
- hypothalamic structures In mammals, two hypothalamic structures are involved in the regulation of the ingestion of food; they are the lateral area known as the hunger center" and the ventromedial nucleus deemed as being the satiety center.
- aphagia see S. E. FELDMAN, S. LARSSON, M. K. DlMlCK and S. LEPKOVSKY, Aphagia in chickens Am. J. Physiol; 191; 1957, pp.259261 and C. J. SMlTH
- hyperphagia see S. LEPKOVSKY, Body composition of male chickens, Poultry Sc. 45, 1966, pp.582588
- the substances known by the name of anticholamine substances are compounds which withstand the formation of catecholamines, sympathomimetic amines derived from catechol or limiting this formation.
- the catecholamines include products such as adrenaline, noradrenaline and dopamine.
- hydroxy-6-dopamine or 6-OH DOPA may be mentioned, among others, as being suited to be used according to the invention.
- a particularly suitable method for administering the said anticatecholamine substance into the cerebrospinal fluid of the animal consists in an injection into the said fluid, preferably with a previously anesthetized animal; but any other mode of administration known to a man skilled in the art for supplying the said active substance into the cerebrospinal fluid may be used.
- an anticatecholamine substance is effected into the third ventricle or in the region of the hypothalamic ventromedial nucleus of the animal.
- the hyperphagia obtained according to the invention is absolutely comparable, and most often superior, to that provided by the destruction of the hypothalamic ventromedial complex of the animal and, apart from the advantages mentioned hereinabove, can be obtained after only one administration or one injection of an anti-catecholamine substance according to the invention.
- anti-catecholamine substances to be administered according to the invention can easily be determined by routine tests.
- the minimum dose is obviously not critical. Only the maximum dose has to be determined as being the upper limit beyond which notable disorders are observed in the animal.
- the optimal amount of 6-OH DOPA to be administered by intraventricular injection is about 250 ug in the case of the goose to provide the hyperphagia induced according to the invention.
- the maximal dose is about 300 ug.
- the rate of 6-OH DOPA used isadvantageously in the range of 30 to 150 ug, preferably from 45 to ,ug.
- a particularly advantageous industrial result obtained by the method of the invention is the production of goose foie gras.
- geese treated according to the invention are geese of the Landaise breed, genetically suited for the production of foie gras.
- EXAMPLE 1 Landaise breed geese were anesthetized by a continuous intravenous perfusion of a l/SO solution of Pentothal" in distilled water. The head of the animal was placed in a stereotaxis apparatus derived from the Horsley and Clarke apparatus, and the goose was maintained by the acoustic duct and the beak.
- Hydroxy-6-dopamine was injected into the third ventricule at a rate of 10 microliters in 5 minutes, using a trocart connected to a precision micropump by a catheter.
- Control animals were also prepared in the same manner but replacing hydroxy-6-dopamine by physiological saline solution.
- the amount of food taken per animal and per day was measured over a period of 35 days.
- the complete, balanced feed supplied consisted of 74% maize. 15% soybean meal, 3% fish meal, mineral salts as oligo-elements and all the necessary vitamins.
- the geese were sacrificed, i.e. slaughtered, at the end of the experiment, the livers being thereafter removed and weighed.
- a dose of hydroxy-6-dopamine smaller than 150 ug administered by intraventicular, injection only produced low levels of hyperphagia which did not last for longer than 10 days.
- a dose of about 250 pg per animal was observed to be particularly advantageous. In this case, food intake was double and even three times that of the control animals.
- the weight of the livers taken from the animals 35 days after the injection varied from 350g to 900g (average 580g) depending on the animal.
- the weight of the livers of the control animals lies in the range of 80 to 160g (average 130g).
- a higher dose than 300 ,ug can cause serious disorders: doses of 500 ug of hydroxy--dopamine were injected to 8 geese; 6 geese died and 2 showed very pronounced hyperphagia.
- EXAMPLE 2 Landaise" breed geese were prepared as described in Example 1 and hydroxy-6-dopamine was administered to them by injection into the hypothalamic ventromedial complex.
- a first injection of l5ug hydroxy-6-dopamine per animal was administered in the hypothalamic ventromedial complex.
- a further dose of 45p.g hydroxy--dopamine was administered in the same manner. The geese then showed significant hyperphagia.
- the livers obtained from animals sacrificed 35 days after the last injection weighed from 220 to 550g (average 380g) whereas the livers of control geese subjected to the treatment described in Example 1 only weighed from 80 to 160g (average g).
- a method for obtaining foie gras by induction of hyperphagia in geese which comprises the administration of an anti-catecholamine substance into the cerebrospinal fluid of the goose in an amount not more than about 300 p. g to induce hyperphagia.
- a method according to claim 1, wherein the mode of administration is an injection into the cerebrospinal fluid of a previously anesthetized goose.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7126768A FR2146640A5 (enExample) | 1971-07-21 | 1971-07-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US3857961A true US3857961A (en) | 1974-12-31 |
Family
ID=9080707
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US00273671A Expired - Lifetime US3857961A (en) | 1971-07-21 | 1972-07-20 | Method for producing foie gras by induction of hyperphagia in geese |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US3857961A (enExample) |
| BG (1) | BG21001A3 (enExample) |
| CA (1) | CA993260A (enExample) |
| FR (1) | FR2146640A5 (enExample) |
| GB (1) | GB1370862A (enExample) |
| HU (1) | HU172313B (enExample) |
| IL (1) | IL39959A (enExample) |
| IT (1) | IT1029520B (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060286151A1 (en) * | 2005-04-27 | 2006-12-21 | Robert Bender | Production of foie gras |
| CN110934099A (zh) * | 2019-11-08 | 2020-03-31 | 上海海洋大学 | 一种利用da受体抑制河蟹打斗的方法 |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8604134D0 (en) * | 1986-02-19 | 1986-03-26 | Glaxo Group Ltd | Veterinary preparations |
-
1971
- 1971-07-21 FR FR7126768A patent/FR2146640A5/fr not_active Expired
-
1972
- 1972-07-19 HU HU72AA00000708A patent/HU172313B/hu unknown
- 1972-07-19 IT IT51632/72A patent/IT1029520B/it active
- 1972-07-19 CA CA147,458A patent/CA993260A/en not_active Expired
- 1972-07-20 IL IL39959A patent/IL39959A/xx unknown
- 1972-07-20 GB GB3397072A patent/GB1370862A/en not_active Expired
- 1972-07-20 US US00273671A patent/US3857961A/en not_active Expired - Lifetime
- 1972-07-20 BG BG021010A patent/BG21001A3/xx unknown
Non-Patent Citations (1)
| Title |
|---|
| Ives, Domestic Geese and Ducks, 1947, Published by Orange Judd Publishing Company, Inc., pages 121 129, inclusive. * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060286151A1 (en) * | 2005-04-27 | 2006-12-21 | Robert Bender | Production of foie gras |
| WO2007000665A3 (en) * | 2005-04-27 | 2007-05-31 | Robert Bender | Production of foie gras |
| CN110934099A (zh) * | 2019-11-08 | 2020-03-31 | 上海海洋大学 | 一种利用da受体抑制河蟹打斗的方法 |
| CN110934099B (zh) * | 2019-11-08 | 2021-09-24 | 上海海洋大学 | 一种利用da受体抑制河蟹打斗的方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CA993260A (en) | 1976-07-20 |
| IT1029520B (it) | 1979-03-20 |
| GB1370862A (en) | 1974-10-16 |
| HU172313B (hu) | 1978-08-28 |
| BG21001A3 (bg) | 1976-01-20 |
| IL39959A0 (en) | 1972-09-28 |
| FR2146640A5 (enExample) | 1973-03-02 |
| IL39959A (en) | 1975-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE4035442B4 (de) | Arzneimittel enthaltend als Wirkstoff R-α-Liponsäure | |
| JPS6144844B2 (enExample) | ||
| DE2527065B2 (de) | S-Propylthio-2-benzimidazolcarbaminsäuremethylester | |
| DE69213757T2 (de) | Verwendung von kreatinphosphat oder phosphoenolbrenztraubensäure zur behandlung von tumoren | |
| EP3064209B1 (en) | Composition comprising ginsenoside f2 for preventing or treating insulin resistance | |
| CN103641841A (zh) | 倍半萜内酯类化合物及其制备方法和应用 | |
| SOLOMON et al. | Cataracts produced in rats by 1, 4-dimethanesulfonoxybutane (Myleran) | |
| Marley et al. | Effects of some catecholamines infused into the hypothalamus of young chickens | |
| US3143469A (en) | Anti-cholesterol nicotinic acid nu-oxide | |
| DE2432393C3 (de) | Arzneipräparat zur Behandlung von bösartigen Neubildungen | |
| Olsen et al. | Hyperglycemia induced by certain insulin preparations. | |
| US2537988A (en) | Sympatholytic compositions | |
| Barnett et al. | Effect of beta-aminopropionitrile on reproduction of chickens. | |
| DE3878063T2 (de) | Resorcylsaeure-lacton-verbindungen zur bekaempfung von helminthes-parasiten. | |
| Sterol et al. | Inhibition of Growth of G3H Mice by Ethionine and its Alleviation by Methionine or Choline. | |
| Gross | Effect of liver damage on urinary morphine excretion | |
| DE2428680C2 (de) | 1-(2',4',6'-Trihydroxyphenyl)-propandion-(1,2)-Verbindungen, Verfahren zu deren Herstellung und Arzneimittel, die diese Verbindungen enthalten | |
| CASIMIR | Research Institute, Brompton, London, SW.) IN previous papers on this subject (1) I have described in detail the methods of preparation of the vitamine-fraction from yeast and other | |
| US3993759A (en) | Anthelmintic | |
| US3956503A (en) | Composition for the treatment and the prevention of heliencephalitis, thermoplegia and other disorders in domestic animals and poultry | |
| DE2061181C3 (de) | Antiarthritisch wirkendes Arzneimittel auf der Basis einer Goldverbindung | |
| DE2748015A1 (de) | Arzneimittel zur heilung von boesartigen neubildungen | |
| Funk | Is polished rice plus vitamine a complete food? | |
| DE3884108T2 (de) | Peptid FK-565, brauchbar zur Kontrolle helminthischer Parasiten. | |
| DE3872749T2 (de) | Anwendung von odc-inhibitoren, dacarbazin und interferon in der behandlung boesartiger melanome. |